Fisher Wallace Laboratories Raises $800K on StartEngine

Click to rate this post!
[Total: 0 Your Rating: 0]

Fisher Wallace Laboratories

Regulation A+ Offering
Medical Devices for Mood and Sleep
$967,211 Raised | 597 Investors
$496.80 Min. Investment

The Fisher Wallace Stimulator comfortably stimulates the brain to produce serotonin and modulate brainwave activity to help patients struggling with depression, anxiety and insomnia. The device has demonstrated a high effectiveness rate and less than a 1% side effect rate in clinical practice. Reasons to invest in Fisher Wallace include:

Path to FDA Approval: With three clinical trials underway to support the approval process, Fisher Wallace was recently granted over-the-counter approval in Europe and Medicaid approval in Maine (MaineCare).
Improved Margins: Fisher Wallace successfully migrated its manufacturing to a high-volume facility that has reduced its cost of goods sold (COGS) by 60%.
Patients who use the device for 20 minutes once or twice a day typically experience symptom reduction within the first week of use. You can invest in Fisher Wallace for as little as $496.80.

Learn More About Fisher Wallace


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.